Biosurgery Market - Growth, Trends, and Forecast (2020 - 2025)
|出版商||Mordor Intelligence LLP||商品編碼||921283|
|出版日期||內容資訊||英文 113 Pages
|生物外科(生物學的外科治療)的全球市場:成長、趨勢、預測 Biosurgery Market - Growth, Trends, and Forecast (2020 - 2025)|
|出版日期: 2020年01月01日||內容資訊: 英文 113 Pages||
The biosurgery market studied was anticipated to grow with a CAGR of 7.4%, during the forecast period. The major factors attributing to the growth of the biosurgery market are increasing geriatric population, rising prevalence of chronic diseases and related surgeries, and a strong focus on R&D leading to the launch of new and advanced products. The global increase in the number of geriatrics population and obese people is likely to lead to numerous health consequences, like greater incidences of ortho and neuro problems. Consequently, the geriatric population and population with obesity are at a higher risk of multiple disorders and diseases. According to the United Nations report in 2017, there were an estimated 962 million people aged 60 or over in the world, comprising 13% of the global population. The population aged 60 or above is growing at a rate of about 3% per year. It was estimated that Europe had the highest percentage of the population aged 60 or over in 2017. Thus, the rise in the geriatric and obese population is acting as a major driver for the growth of the biosurgery market.
Biosurgery products are used in various surgeries and repair weakened and damaged tissues and bones. Biosurgery has opened a new paradigm in surgical care, wound and tissue management, and regenerative healing. It has even unlocked new potential in regenerative healing with the right mix of biologics and synthetics.
Neurology Segment is Expected to Grow with Good CAGR in the Application Segment
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall market, throughout the forecast period. This is due to the increasing number of surgeries, rising obese patients and increasing geriatric population. In the North America region, the United States holds the largest market share due to factors such as increasing count of geriatrics, along with the growing healthcare industry, which is anticipated to stimulate the demand in this region. Substantial investments by governments to strengthen public healthcare delivery is a key factor augmenting the growth of the market.
The biosurgery market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the prominent players are vigorously making acquisitions with the other companies to consolidate their market positions across the globe. Companies that are currently vying for a greater revenue share in the global biosurgery market are Baxter International Inc., Johnson & Johnson, Becton Dickinson and Company (C.R. Bard), B. Braun Melsungen AG, CryoLife, Inc.